Evidence map›Paper›PMID 36593021›Full record

ArticleIn vivo (Athens, Greece)

Advanced Reconstruction of Vesicourethral Support May Improve Urinary Continence and Quality of Life After Non-nerve-sparing Robot-assisted Radical Prostatectomy.

Katsuya Hikita, Masashi Honda, Ryutaro Shimizu, Ryoma Nishikawa, Shogo Teraoka, Yusuke Kimura, Noriya Yamaguchi, Hideto Iwamoto, Shuichi Morizane, Atsushi Takenaka

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Katsuya HikitaDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan k-hikita@tottori-u.ac.jp.
Masashi HondaDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Ryutaro ShimizuDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Ryoma NishikawaDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Shogo TeraokaDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Yusuke KimuraDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Noriya YamaguchiDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Hideto IwamotoDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Shuichi MorizaneDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Atsushi TakenakaDivision of Urology, Department of Surgery, Tottori University Faculty of Medicine, Tottori, Japan.
Tottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimPostoperative urinary incontinence (UI) after robot-assisted radical prostatectomy (RARP) has a significant impact on patients' quality of life (QOL). Several surgical techniques have been reported to improve postoperative UI. The aim of the study was to investigate the impact of advanced reconstruction of vesicourethral support (ARVUS) on urinary symptoms and QOL after non-nerve-sparing robot-assisted radical prostatectomy (RARP). PATIENTS AND

methodsPatients who underwent non-nerve-sparing RARP from October 2010 to October 2020 at the Division of Urology, Department of Surgery, Tottori University Faculty of Medicine were reviewed. Patients were divided into the ARVUS and non-ARVUS groups, and propensity score matching was performed. Patients were evaluated by the International Prostate Symptom Score (IPSS), Incontinence Modular Questionnaire Short Form (ICIQ-SF), QOL index, and number of pads used before and 1, 3, 6, and 12 months after RARP.

resultsThe number of patients in the ARVUS and non-ARVUS group were 41 and 41, respectively. On cystography, the distance of the symphysis pubis to the bladder neck was significantly shorter (p<0.001) and the posterior urethrovesical angle was significantly smaller in the AUVUS group (p<0.001). In the ICIQ-SF, the ARVUS group was significantly better at 6 and 12 months postoperatively. In the IPSS, the ARVUS group was significantly better than the non-ARVUS group at 3 months postoperatively. In a multivariable analysis, membranous urethral length [odds ratio (OR)=3.44, p=0.015] and ARVUS (OR=2.72, p=0.046) were significant factors in achieving 0 pads and total ICIQ-SF Question 1 and 2 scores of ≤2 at 12 months postoperatively.

conclusionARVUS improved urinary symptoms and QOL. ARVUS seems to be a useful surgical procedure for non- nerve-sparing RARP.

Indexed as

Prostatic NeoplasmsRoboticsUrinary IncontinenceHumansMaleProstateProstatectomyQuality of LifeUrinary BladderProstatectomyreconstructive surgical proceduresretrospective studyroboticsurinary incontinence

Identifiers

PMID36593021
PMCPMC9843809
OpenAlexW4313474787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.